أعرض في EDS

CLN2 disease (neuronal ceroid lipofuscinosis type 2): Experience in the real world with cerliponase alfa intracerebroventricular enzyme replacement therapy in a public hospital in Cordoba, Argentina

التفاصيل البيبلوغرافية
العنوان: CLN2 disease (neuronal ceroid lipofuscinosis type 2): Experience in the real world with cerliponase alfa intracerebroventricular enzyme replacement therapy in a public hospital in Cordoba, Argentina
المؤلفون: Victor Munoz, Guillermo Guelbert, Francisco Pueyrredon, Guillermo Seratti, Roberto Caraballo, Norberto Guelbert, Raul Jalil, Tatiana Rodrigo, Daniel Velazquez
المصدر: Molecular Genetics and Metabolism. 123:S128
بيانات النشر: Elsevier BV, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Disease, Enzyme replacement therapy, Cerliponase alfa, Biochemistry, Neuronal Ceroid Lipofuscinosis Type 2, Endocrinology, Public hospital, Genetics, Medicine, business, Molecular Biology
تدمد: 1096-7192
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1efc7cefb0cb611f6174c8bfcdd184beTest
https://doi.org/10.1016/j.ymgme.2017.12.349Test
حقوق: CLOSED
رقم الانضمام: edsair.doi...........1efc7cefb0cb611f6174c8bfcdd184be
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10967192